Published in Lab Business Week, January 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Frost & Sullivan.
Report 1: Biopharmaceutical products are considerably more expensive than traditional ones, largely due to the high-cost technology required for production.
Apart from the various investments in the development and registration of new drugs, meeting regulatory specifications can take 6-12 years and the entire product launch can cost $200-500 million, according to research from Frost & Sullivan.
To successfully introduce drugs, product...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.